Obalon down 32% on soft Q1 sales [Seeking Alpha]
OBALON THERAPEUTICS (OBLN)
Last obalon therapeutics earnings: 11/8 07:15 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.obalon.com
Company Research
Source: Seeking Alpha
Obalon down 32% on soft Q1 salesThinly traded nano cap Obalon Therapeutics (OBLN-31.5%) slumps on more than a 4x surge in volume, albeit on turnover of only 277K shares, in response to itsQ1 results that fell shy of consensus.Revenues of $1.3M were down 13% despite the company's announcement of the highest number of treating accounts and treated patients in history.Previously:Obalon Therapeutics misses by $0.21, misses on revenue (May 10)See all stocks on the move »Now read:BioLife Solutions, Inc. 2018 Q1 - Results - Earnings Call Slides »
Show less
Read more
Impact Snapshot
Event Time:
OBLN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OBLN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OBLN alerts
High impacting OBALON THERAPEUTICS news events
Weekly update
A roundup of the hottest topics